H

Hospital El Cruce | Area de Investigacion

Research site
(Unclaimed)
Location
Avenida Calchaqui 5401, Florencio Varela, Buenos Aires, Argentina
Site insights

Top conditions

Syndrome (3 trials)

Myocardial Infarction (2 trials)

Infarction (2 trials)

Amyloidosis (2 trials)

Polyneuropathies (2 trials)

Top treatments

Eplontersen
ION-682884
Lampalizumab
BMS-986165
Deucravacitinib

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

2 of 13
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study to Assess the Long-Term Safety and Efficacy of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Patients With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy

The purpose of this study is to evaluate the safety and tolerability of extended dosing with Eplontersen in participants with hereditary transthyreti...

Enrolling
Hereditary Transthyretin-Mediated Amyloid Polyneuropathy
Drug: Eplontersen

The purpose of this study is to evaluate the effectiveness and safety of deucravacitinib compared with placebo in an active moderate to severe System...

Enrolling
Systemic Lupus Erythematosus
Other: Placebo
Drug: Deucravacitinib

Trial sponsors

H

Hospital El Cruce (5 trials)

Ionis Pharmaceuticals logo

Ionis Pharmaceuticals (2 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems